316 related articles for article (PubMed ID: 7696203)
21. The role of lipid antigen presentation, cytokine balance, and major histocompatibility complex in a novel murine model of adoptive transfer of insulitis.
Ylinen L; Teros T; Liukas A; Arvilommi P; Sainio-Pöllänen S; Veräjänkorva E; Pöllänen P; Simell O
Pancreas; 2000 Mar; 20(2):197-205. PubMed ID: 10707937
[TBL] [Abstract][Full Text] [Related]
22. Transgenic mice expressing constitutive levels of IL-2 in islet beta cells develop diabetes.
Elliott EA; Flavell RA
Int Immunol; 1994 Nov; 6(11):1629-37. PubMed ID: 7865456
[TBL] [Abstract][Full Text] [Related]
23. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.
Bergerot I; Fabien N; Maguer V; Thivolet C
Clin Exp Immunol; 1995 Nov; 102(2):335-40. PubMed ID: 7586687
[TBL] [Abstract][Full Text] [Related]
25. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
26. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
27. Insulin-dependent diabetes in the NOD mouse model. I. Detection and characterization of autoantibody bound to the surface of pancreatic beta cells prior to development of the insulitis lesion in prediabetic NOD mice.
Shieh DC; Cornelius JG; Winter WE; Peck AB
Autoimmunity; 1993; 15(2):123-35. PubMed ID: 8218837
[TBL] [Abstract][Full Text] [Related]
28. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T
J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
30. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
31. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
Peterson JD; Pike B; McDuffie M; Haskins K
J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683
[TBL] [Abstract][Full Text] [Related]
32. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice.
Sumida T; Furukawa M; Sakamoto A; Namekawa T; Maeda T; Zijlstra M; Iwamoto I; Koike T; Yoshida S; Tomioka H
Int Immunol; 1994 Sep; 6(9):1445-9. PubMed ID: 7819154
[TBL] [Abstract][Full Text] [Related]
33. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
34. Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10.
Kawamoto S; Nitta Y; Tashiro F; Nakano A; Yamato E; Tahara H; Tabayashi K; Miyazaki J
Int Immunol; 2001 May; 13(5):685-94. PubMed ID: 11312256
[TBL] [Abstract][Full Text] [Related]
35. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
Martignat L; Feve B; Charbonnel B; Sai P
Diabete Metab; 1993; 19(6):566-74. PubMed ID: 8026608
[TBL] [Abstract][Full Text] [Related]
36. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
38. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.
Muir A; Peck A; Clare-Salzler M; Song YH; Cornelius J; Luchetta R; Krischer J; Maclaren N
J Clin Invest; 1995 Feb; 95(2):628-34. PubMed ID: 7860747
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
40. The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse.
Mollah ZU; Wali J; McKenzie MD; Krishnamurthy B; Graham KL; Fynch S; Szanyi J; Santamaria P; Brodnicki T; Allison J; Strasser A; Kay TW; Thomas HE
Apoptosis; 2011 Aug; 16(8):822-30. PubMed ID: 21644000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
